pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search

calendar

7,806 catalysts · 5,539 phase readout · 2,261 8k filing · 224 earnings · 3 pdufa · 2 approval · 1 adcom

★ save view↓export CSV
next 91 dayslessmore
MonWedFri
2026-08-03: 0 catalysts2026-08-04: 0 catalysts2026-08-05: 18 catalysts2026-08-06: 12 catalysts2026-08-07: 1 catalyst2026-08-08: 0 catalysts2026-08-09: 0 catalysts2026-08-10: 2 catalysts2026-08-11: 1 catalyst2026-08-12: 2 catalysts2026-08-13: 2 catalysts2026-08-14: 1 catalyst2026-08-15: 0 catalysts2026-08-16: 0 catalysts2026-08-17: 0 catalysts2026-08-18: 1 catalyst2026-08-19: 0 catalysts2026-08-20: 0 catalysts2026-08-21: 0 catalysts2026-08-22: 0 catalysts2026-08-23: 0 catalysts2026-08-24: 0 catalysts2026-08-25: 0 catalysts2026-08-26: 0 catalysts2026-08-27: 0 catalysts2026-08-28: 0 catalysts2026-08-29: 0 catalysts2026-08-30: 0 catalysts2026-08-31: 0 catalysts2026-09-01: 1 catalyst2026-09-02: 0 catalysts2026-09-03: 0 catalysts2026-09-04: 0 catalysts2026-09-05: 0 catalysts2026-09-06: 0 catalysts2026-09-07: 0 catalysts2026-09-08: 0 catalysts2026-09-09: 0 catalysts2026-09-10: 0 catalysts2026-09-11: 0 catalysts2026-09-12: 0 catalysts2026-09-13: 0 catalysts2026-09-14: 0 catalysts2026-09-15: 0 catalysts2026-09-16: 0 catalysts2026-09-17: 0 catalysts2026-09-18: 0 catalysts2026-09-19: 0 catalysts2026-09-20: 0 catalysts2026-09-21: 0 catalysts2026-09-22: 0 catalysts2026-09-23: 1 catalyst2026-09-24: 0 catalysts2026-09-25: 0 catalysts2026-09-26: 0 catalysts2026-09-27: 0 catalysts2026-09-28: 0 catalysts2026-09-29: 0 catalysts2026-09-30: 0 catalysts2026-10-01: 0 catalysts2026-10-02: 0 catalysts2026-10-03: 0 catalysts2026-10-04: 0 catalysts2026-10-05: 0 catalysts2026-10-06: 0 catalysts2026-10-07: 0 catalysts2026-10-08: 0 catalysts2026-10-09: 0 catalysts2026-10-10: 0 catalysts2026-10-11: 0 catalysts2026-10-12: 0 catalysts2026-10-13: 1 catalyst2026-10-14: 1 catalyst2026-10-15: 0 catalysts2026-10-16: 0 catalysts2026-10-17: 0 catalysts2026-10-18: 0 catalysts2026-10-19: 0 catalysts2026-10-20: 2 catalysts2026-10-21: 1 catalyst2026-10-22: 2 catalysts2026-10-23: 0 catalysts2026-10-24: 0 catalysts2026-10-25: 0 catalysts2026-10-26: 0 catalysts2026-10-27: 2 catalysts2026-10-28: 1 catalyst2026-10-29: 3 catalysts2026-10-30: 2 catalysts2026-10-31: 0 catalysts2026-11-01: 0 catalysts
view
agendamonth
show past →
sort
soonestlatesttypesponsoralpha
type
  • phase readout5,539
  • 8k filing2,261
  • earnings224
  • pdufa3
  • approval2
  • adcom1
therapy area

no tagged catalysts yet

Date TBD

50
›COMPLETEDphase readoutNCT04864067: No Operation After Short Course Radiotherapy Followed By Consolidation Chemotherapy In Locally Advanced Rectal Cancer

Sponsor: Servicio de Salud Metropolitano Sur Oriente. Phase: PHASE2. Conditions: Rectal Cancer

full page →ctgov ↗
›RECRUITINGphase readoutNCT06613100: Evaluation of Neoadjuvant Xaluritamig in Localized Prostate Cancer

Sponsor: Amgen. Phase: PHASE1. Conditions: Prostate Cancer

full page →ctgov ↗
›RECRUITINGphase readoutNCT06934200: Omalizumab for the Treatment of Food Allergy in Patients With Elevated Total IgE Levels

Sponsor: Johns Hopkins University. Phase: PHASE2. Conditions: Food Hypersensitivity

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT05935800: The Effect of the COVID-19 Pandemic on Frailty in Liver Transplant Candidates

Sponsor: Methodist Health System. Phase: . Conditions: Frailty, Sarcopenia, COVID-19

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07638800: Phase 1 Clinical Study of GenSci155 Injection in Healthy Adults

Sponsor: Changchun GeneScience Pharmaceutical Co., Ltd.. Phase: PHASE1. Conditions: Healthy Adult Trial Participants

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT05955300: Nutrition and Movement to Improve Quality of Life With Knee Osteoarthritis

Sponsor: St. Pölten University of Applied Sciences. Phase: NA. Conditions: Osteo Arthritis Knee

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07609836: Caudal Dexamethasone - Bupivacaine in Neonates

Sponsor: Ain Shams University. Phase: NA. Conditions: We Are Studying the Effects of Caudal Dexamethasone in Neonates Undergoing Inguinal Hernia Repair

full page →ctgov ↗
›COMPLETEDphase readoutNCT03262636: Two-Part Study to Evaluate the Safety and Efficacy of Image Guided Surgery Using Indocyanine Green for Intramolecular Imaging of Nervous System Tumors Compared to Standard of Care, (TumorGlow)

Sponsor: University of Pennsylvania. Phase: PHASE1. Conditions: Brain Tumor, Primary, Brain Tumor, Recurrent

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07349836: Application of mRNA Immunotherapy Technology in EB Virus Related Diseases

Sponsor: Xinqiao Hospital of Chongqing. Phase: EARLY_PHASE1. Conditions: EBV-associated Tumors

full page →ctgov ↗
›RECRUITINGphase readoutNCT07583836: DELAYED VERSUS EARLY SURGICAL DECOMPRESSION FOR TRAUMATIC SPINAL CORD INJURY

Sponsor: Fauji Foundation Hospital. Phase: . Conditions: Traumatic Spinal Cord Injury

full page →ctgov ↗
›RECRUITINGphase readoutNCT07367971: Drug-Drug Interaction Study of ABP-671 in Gout Patients

Sponsor: Atom Therapeutics Co., Ltd. Phase: PHASE1. Conditions: Gout Chronic, Gout, DDI (Drug-Drug Interaction)

full page →ctgov ↗
›RECRUITINGphase readoutNCT07380334: A Clinical Study on the Safety, Tolerability, Pharmacokinetics and Efficacy of SHR-1049 in Patients With Advanced Solid Tumors

Sponsor: Jiangsu HengRui Medicine Co., Ltd.. Phase: PHASE1. Conditions: Advanced Solid Tumor

full page →ctgov ↗
›RECRUITINGphase readoutNCT06777134: Relationship Between Pelvic Floor Dysfunctions and Lower Limb Strength and Activation in MS Patients

Sponsor: Berivan Beril Kılıç. Phase: . Conditions: Multiple Sclerosis, Pelvic Floor Dysfunction

full page →ctgov ↗
›RECRUITINGphase readoutNCT07568509: Identifying Oxytocin Deficiency in Pediatric Patients With Pituitary Disease

Sponsor: Massachusetts General Hospital. Phase: EARLY_PHASE1. Conditions: Arginine Vasopressin Deficiency, Oxytocin Deficiency, Pediatric Disease, Hypopituitarism

full page →ctgov ↗
›RECRUITINGphase readoutNCT07004699: Comparison of Two Ventilation Methods During Endoscopy of the Pharynx, Larynx and Oesophagus

Sponsor: Poitiers University Hospital. Phase: NA. Conditions: Oxygen Inhalation Therapy Endoscopy

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT05553132: A Study of REcycled CartiLage Auto/Allo IMplantation to Treat and Repair Focal Hip Cartilage Defects

Sponsor: Daniel B. F. Saris. Phase: PHASE1. Conditions: Cartilage Defect

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07640932: Lurbinectedin Plus Paclitaxel Versus Paclitaxel in Patients With Previously Treated Small Cell Lung Cancer

Sponsor: Yonsei University. Phase: PHASE2. Conditions: Carcinoma, Small Cell Lung

full page →ctgov ↗
›COMPLETEDphase readoutNCT06216132: Study of the BIOPIN 6 Naltrexone Implant in Healthy Adults

Sponsor: Akyso Therapeutics, LLC. Phase: PHASE1. Conditions: Opioid Use Disorder

full page →ctgov ↗
›COMPLETEDphase readoutNCT06438263: A Study to Evaluate Bioavailability of Rocatinlimab Autoinjector and Vial in Healthy Participants

Sponsor: Amgen. Phase: PHASE1. Conditions: Atopic Dermatitis

full page →ctgov ↗
›COMPLETEDphase readoutNCT06011187: Assisted Fluid Management (AFM) System and Postoperative Outcome After High-risk Abdominal Surgery

Sponsor: Assistance Publique - Hôpitaux de Paris. Phase: NA. Conditions: Decision Support System, Outcome

full page →ctgov ↗
›COMPLETEDphase readoutNCT01073787: Intravenous Fluid for Pediatric Migraine in the Emergency Department

Sponsor: University of Alberta. Phase: PHASE1. Conditions: Migraine, Headache

full page →ctgov ↗
›COMPLETEDphase readoutNCT03575221: Natural History of the Collagen-Related Disorder Osteogenesis Imperfecta and Genotype Phenotype Correlation

Sponsor: Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD). Phase: . Conditions: Osteogenesis Imperfecta, Short Stature

full page →ctgov ↗
›COMPLETEDphase readoutNCT07616193: Interaction Between Spasticity and the Initial Response After Balance Perturbations in Children With Spastic Cerebral Palsy

Sponsor: Universitaire Ziekenhuizen KU Leuven. Phase: . Conditions: Cerebral Palsy (CP), Typically Developing Children

full page →ctgov ↗
›RECRUITINGphase readoutNCT06015893: Semaglutide Therapy for Alcohol Reduction (STAR)

Sponsor: National Institute on Drug Abuse (NIDA). Phase: PHASE2. Conditions: Addiction, Alcohol Use Disorder

full page →ctgov ↗
›RECRUITINGphase readoutNCT04936620: Duroplasty for Injured Cervical Spinal Cord With Uncontrolled Swelling

Sponsor: St George's, University of London. Phase: NA. Conditions: Spinal Cord Injuries

full page →ctgov ↗
›RECRUITINGphase readoutNCT07092982: Comparison of Two Different Regional Anesthetic Methods in Total Knee Arthroplasty Patients

Sponsor: SB Istanbul Education and Research Hospital. Phase: NA. Conditions: Total Knee Arthroplasty, Ultrasound Guided Supra-inguinal Fascia Iliaca Block, Adductor Canal Block

full page →ctgov ↗
›RECRUITINGphase readoutNCT06630780: Reduction of Postoperative Radiotherapy in Head and Neck Squamous Cell Carcinoma

Sponsor: Sun Yat-sen University. Phase: NA. Conditions: Head and Neck Squamous Cell Carcinoma (HNSCC)

full page →ctgov ↗
›RECRUITINGphase readoutNCT06104280: Medications for Opioid Use Disorder Photosensitive Retinal Ganglion Cell Function, Sleep, and Circadian Rhythms: Implications for Treatment

Sponsor: University of Alabama at Birmingham. Phase: . Conditions: Opioid Use Disorder, Sleep Disturbance

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07647380: TIS for Improving Cognitive Impairment in Schizophrenia

Sponsor: Central South University. Phase: NA. Conditions: Schizophrenia Disorder, Cognitive Impairments

full page →ctgov ↗
›COMPLETEDphase readoutNCT04443062: Lutetium-177-PSMA-617 in Oligo-metastatic Hormone Sensitive Prostate Cancer

Sponsor: Radboud University Medical Center. Phase: PHASE2. Conditions: Prostate Cancer

full page →ctgov ↗
›COMPLETEDphase readoutNCT07477262: Health Effects of a Walking Program in a High-Quality Tourism Environment for Older Women

Sponsor: Yu-fan Li. Phase: NA. Conditions: Overweight , Obesity

full page →ctgov ↗
›COMPLETEDphase readoutNCT01999062: Automated Breast Radiation Therapy Using an MR-Guided Process

Sponsor: University Health Network, Toronto. Phase: NA. Conditions: Breast Cancer

full page →ctgov ↗
›COMPLETEDphase readoutNCT02866162: Screening for Genes in Patients With Congenital Neutropenia

Sponsor: Centre Hospitalier Universitaire Dijon. Phase: . Conditions: Congenital Neutropenia

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT07443761: Patients Undergoing Pancreatic Surgery at the Antwerp University Hospital.

Sponsor: University Hospital, Antwerp. Phase: . Conditions: Benign Pancreas Tumor, Malignant Pancreatic Neoplasm

full page →ctgov ↗
›COMPLETEDphase readoutNCT07047261: Efficacy of a Xanthan-based Chlorhexidine Gel in the Treatment of Peri-implant Mucositis

Sponsor: University of Turin, Italy. Phase: NA. Conditions: Peri-implant Mucositis

full page →ctgov ↗
›RECRUITINGphase readoutNCT06459986: The Duration of Spinal Anaesthesia - a Prospective, Observational Cohort Study

Sponsor: Nordsjaellands Hospital. Phase: . Conditions: Orthopedic Disorder

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07316270: SAfety and eFfectiveness of cathetER Ablation for Atrial Fibrillation With Intracerebral Hemorrhage (SAFER-AF)

Sponsor: Beijing Anzhen Hospital. Phase: NA. Conditions: AF - Atrial Fibrillation, ICH - Intracerebral Hemorrhage

full page →ctgov ↗
›COMPLETEDphase readoutNCT02410473: Evaluation of Coagulation Testing in Patients Undergoing Cardiac Surgery

Sponsor: Boston Children's Hospital. Phase: . Conditions: Congenital Heart Disease

full page →ctgov ↗
›RECRUITINGphase readoutNCT06318169: A Study Evaluating the Efficacy and Safety of Pegozafermin in Participants With MASH and Fibrosis (ENLIGHTEN-Fibrosis)

Sponsor: 89bio, Inc.. Phase: PHASE3. Conditions: Metabolic Dysfunction-Associated Steatotic Liver Disease (MASH) / Nonalcoholic Steatohepatitis (NASH) With Fibrosis

full page →ctgov ↗
›COMPLETEDphase readoutNCT07110441: Pharmacokinetic Study on G1090N (Nitazoxanide) Capsules in Healthy Volunteers

Sponsor: Genfit. Phase: PHASE1. Conditions: Acute-on-Chronic Liver Failure

full page →ctgov ↗
›RECRUITINGphase readoutNCT07607054: A First-in-human Phase I Study to Evaluate EMB-15 in Patients With Locally Advanced or Metastatic Solid Tumors.

Sponsor: Shanghai EpimAb Biotherapeutics Co., Ltd.. Phase: PHASE1. Conditions: Locally Advanced or Metastatic Solid Tumors

full page →ctgov ↗
›RECRUITINGphase readoutNCT06482905: Safety and Efficacy Study of TX103 CAR-T Cell Therapy for Recurrent or Progressive Grade 4 Glioma.

Sponsor: Tcelltech Inc.. Phase: PHASE1. Conditions: High-grade Glioma, WHO Grade Ⅳ Glioma

full page →ctgov ↗
›RECRUITINGphase readoutNCT03552705: The Effects of Tranexamic Acid on Joint Inflammation and Cartilage Health in Anterior Cruciate Ligament Injured Patients

Sponsor: Stanford University. Phase: PHASE2. Conditions: Anterior Cruciate Ligament Reconstruction

full page →ctgov ↗
›RECRUITINGphase readoutNCT07483294: Cerebellum-based Imaging Neural Markers for Antipsychotic Response

Sponsor: Northwell Health. Phase: PHASE4. Conditions: Psychosis; Acute

full page →ctgov ↗
›COMPLETEDphase readoutNCT07335666: Virtual Reality Outperforms Game Card Distraction in Reducing Distress During Pediatric Wound Care

Sponsor: Agri Ibrahim Cecen University. Phase: NA. Conditions: Pediatric Wounds, Procedural Pain, Procedure-Related Anxiety, Procedural Fear

full page →ctgov ↗
›RECRUITINGphase readoutNCT05403151: Controls and Healthy Vasculature Initiative

Sponsor: National Heart, Lung, and Blood Institute (NHLBI). Phase: . Conditions: Vascular And Immunologic Diseases, Healthy Volunteers

full page →ctgov ↗
›RECRUITINGphase readoutNCT06493851: The Effect of Hyperbaric Oxygen Therapy for Acceleration Recovery After Anterior Cruciate Ligament Reconstruction(ACLR)

Sponsor: Assaf-Harofeh Medical Center. Phase: NA. Conditions: Anterior Cruciate Ligament Reconstruction

full page →ctgov ↗
›TERMINATEDphase readoutNCT06779851: A Study to Evaluate Safety and Tolerability of BPT567 in Patients With Advanced Solid Tumors

Sponsor: Bright Peak Therapeutics Inc. Phase: PHASE1. Conditions: Advanced Solid Tumors

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT05860751: The Effect of Dry Needling With Electrical Stimulation on Individuals With Restless Legs Syndrome

Sponsor: Mayo Clinic. Phase: NA. Conditions: Neck Pain

full page →ctgov ↗
›COMPLETEDphase readoutNCT05794451: Developing an Artificial Intelligence System to Detect Cognitive Impairment

Sponsor: University of Haifa. Phase: . Conditions: Alzheimer Disease, Healthy Aging, Mild Cognitive Impairment

full page →ctgov ↗
← prev
page 105 of 157
next →